FindTrial
Sign In

Eyelid cancers at Siriraj Hospital, Thailand: 10-year Retrospective Study

Eyelid cancers at Siriraj Hospital, Thailand: 10-year Retrospective Study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20221004005
Enrollment
44
Registered
2022-10-04
Start date
2022-08-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyelid cancers at Siriraj Hospital, Thailand: 10-year Retrospective Study Eyelid cancers, Siriraj Hospital

Interventions

Eyelid cancers at Siriraj Hospital
Screening
Eyelid cancers

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Aged over 18 years 2) Diagnosis of eyelid cancer by pathological examination 3) Undergoing eyelid cancer treatment at Siriraj Hospital

Exclusion criteria

Exclusion criteria: 1) Patients with benign tumors 2) Patients who are not diagnosed by pathological results.

Design outcomes

Primary

MeasureTime frame
Eyelid Malignancy causes first visit Eyelid Malignancy risk factor—

Secondary

MeasureTime frame
Demographic Data first visit Gender, Age, Chief complaint, Laterality, Location, Size, Eyelid Malignancy,Treatment outcome at 0,1,2,3,4,5 year Recurrence, 5-year Survival rate, Eyelid Malignancy—

Countries

Thailand

Contacts

Public ContactAssoc. Prof. Kanograt Pornpanich

Faculty of Medicine Siriraj Hospital, Mahidol University

kanogratpornpanich@gmail.com024198037

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026